BIOMAT Database Logo BIOMAT Database Logo

[Prostaglandin E1, E2 and their metabolites]. 2010

Fumiaki Kojima, and Koh-ichi Yuhki, and Hitoshi Kashiwagi, and Fumitaka Ushikubi
Department of Pharmacology, Asahikawa Medical College.

UI MeSH Term Description Entries
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000527 Alprostadil A potent vasodilator agent that increases peripheral blood flow. PGE1,Prostaglandin E1,Caverject,Edex,Lipo-PGE1,Minprog,Muse,PGE1alpha,Prostaglandin E1alpha,Prostavasin,Prostin VR,Prostine VR,Sugiran,Vasaprostan,Viridal,Lipo PGE1
D015232 Dinoprostone The most common and most biologically active of the mammalian prostaglandins. It exhibits most biological activities characteristic of prostaglandins and has been used extensively as an oxytocic agent. The compound also displays a protective effect on the intestinal mucosa. PGE2,PGE2alpha,Prostaglandin E2,Prostaglandin E2alpha,PGE2 alpha,Prepidil Gel,Prostaglandin E2 alpha,Prostenon,E2 alpha, Prostaglandin,E2, Prostaglandin,E2alpha, Prostaglandin,Gel, Prepidil,alpha, PGE2,alpha, Prostaglandin E2

Related Publications

Fumiaki Kojima, and Koh-ichi Yuhki, and Hitoshi Kashiwagi, and Fumitaka Ushikubi
[Prostaglandin E1, E2 and their metabolites].
November 1999, Nihon rinsho. Japanese journal of clinical medicine,
Fumiaki Kojima, and Koh-ichi Yuhki, and Hitoshi Kashiwagi, and Fumitaka Ushikubi
[Prostaglandin E1, E2 and their metabolites].
August 2005, Nihon rinsho. Japanese journal of clinical medicine,
Fumiaki Kojima, and Koh-ichi Yuhki, and Hitoshi Kashiwagi, and Fumitaka Ushikubi
[Prostaglandin E1 and its metabolites].
March 1995, Nihon rinsho. Japanese journal of clinical medicine,
Fumiaki Kojima, and Koh-ichi Yuhki, and Hitoshi Kashiwagi, and Fumitaka Ushikubi
[Prostaglandin E2 and its metabolites].
March 1995, Nihon rinsho. Japanese journal of clinical medicine,
Fumiaki Kojima, and Koh-ichi Yuhki, and Hitoshi Kashiwagi, and Fumitaka Ushikubi
Asymmetric total synthesis of (minus)-prostaglandin E1 and (minus)-prostaglandin E2.
February 1975, Journal of the American Chemical Society,
Fumiaki Kojima, and Koh-ichi Yuhki, and Hitoshi Kashiwagi, and Fumitaka Ushikubi
A radioimmunoassay for the unstable pulmonary metabolites of prostaglandin E1 and E2: an indirect index of their in vivo disposition and pharmacokinetics.
February 1982, The Journal of pharmacology and experimental therapeutics,
Fumiaki Kojima, and Koh-ichi Yuhki, and Hitoshi Kashiwagi, and Fumitaka Ushikubi
THE BIOLOGICAL ACTIVITY OF PROSTAGLANDIN E1, E2 AND E3.
December 1963, Acta physiologica Scandinavica,
Fumiaki Kojima, and Koh-ichi Yuhki, and Hitoshi Kashiwagi, and Fumitaka Ushikubi
Antagonism of prostaglandin E1 and E2 fever by catecholamines.
January 1979, Research communications in chemical pathology and pharmacology,
Fumiaki Kojima, and Koh-ichi Yuhki, and Hitoshi Kashiwagi, and Fumitaka Ushikubi
Comparison of prostaglandin E1- and prostaglandin E2-induced hyperalgesia in the rat.
September 1994, Neuroscience,
Fumiaki Kojima, and Koh-ichi Yuhki, and Hitoshi Kashiwagi, and Fumitaka Ushikubi
In vivo formation of prostaglandin E1 and prostaglandin E2 in atopic dermatitis.
March 1997, The British journal of dermatology,
Copied contents to your clipboard!